What's breaking now, across thousands of outlets.
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Enrollees must jump through more hoops to verify their income and residency status before receiving subsidies for Affordable Care Act plans.
A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients from suffering kidney damage, according to the results of a major trial now published in JAMA.
The Federal Government says Nigeria could declare the Ebola outbreak over as early as December 7, 2026, if no further confirmed or probable cases are detected.
(MedPage Today) -- Men with very high-risk prostate cancer had a significantly lower risk of metastasis when they received darolutamide (Nubeqa) in addition to androgen deprivation therapy (ADT) and…
(MedPage Today) -- During an appointment with her psychiatrist, a 50-year-old woman with bipolar disorder reported new symptoms of tremor in both hands, slurred speech, and blurred vision.
Infants whose mothers smoked cannabis while breastfeeding showed the presence of volatile organic compounds in their urine, a study shows.
